Level C· Early human research exploring benefitsProspective StudyPubMed

Characteristics of mesenchymal stromal cells isolated from patients with breast cancer.

Pinevich AA., Samoilovich MP., Shashkova OA., Vartanyan NL., Polysalov VN., Kiseleva LN.

Prospective Study, published in Bull Exp Biol Med (2014) — summary generated from the PubMed abstract.

Open my reading list
Level C· Early human research exploring benefitsEvidence level of this study

Early human evidence such as case series or small samples is exploring possible benefits.

  • Level A · Stronger Clinical Evidence
  • Level B · Emerging clinical evidence with positive signals
  • Level C · Early human research exploring benefits
  • Level D · Scientific groundwork from lab and animal studies
  • Emerging · Emerging topic under active research
Read the A–D evidence level guide

This page is generated from the PubMed record. The Thai description is an automated summary of bibliographic fields and the abstract, not a full translation, and is not medical advice.

Study type
Prospective Study
Journal
Bull Exp Biol Med (2014)
Country
United States
Reported sample size
—
Source database
PubMed
PMID
25257437
DOI
10.1007/s10517-014-2640-8

Abstract (original English)

Mesenchymal stromal cells were isolated from the adipose tissue obtained during surgery for breast cancer and cultured under conditions of normal or low oxygen concentrations. In patients that had received a course of radiation and polychemotherapy prior to surgery, the proliferative potential of mesenchymal stromal cells was irreversibly disturbed. In patients receiving no therapy prior to surgery, the morphological, growth, phenotypic, and differentiation characteristics of mesenchymal stromal cells did not differ from the corresponding parameters of mesenchymal stromal cells from healthy donors. Culturing under hypoxic conditions increased adipogenic differentiation potencies of mesenchymal stromal cells from donors and patients.

What this study does not prove

  • • This study does not prove SVF is an approved treatment or a replacement for standard care.

Evidence level

Early human evidence such as case series or small samples is exploring possible benefits.

How we grade evidence
Breast NeoplasmsFemaleHumansImmunophenotypingMesenchymal Stem Cells

Browse all related research

Filter the research library by this study's title keywords, author, or publication year.